NEW YORK (GenomeWeb) – Embark Veterinary announced today that it has raised $4.5 million in order to expand its suite of canine genetic tests. The consumer genomics company said it has also relocated its headquarters.

According to Embark, its latest round of financing was led by Cambridge, Massachusetts-based Founder Collective, San Francisco-based Freestyle Capital, and Third Kind, a New York venture capital fund.